/Investor DB

re.Mind Capital — Full Portfolio

7 tracked investments · listed companies and verified rows first

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRAOct 2021

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more

Anna Healthannaautismcare.comNov 2024 · $9M

ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching.

Digital HealthHealthtechWellness & FitnessBoston, US

Aimun Malik(Executive Officer, Director, Promoter)

BoardBinoy Bhansali(Director)Sean Doolan(Director)in

Co-investorsGreyMatterMute VenturesVirtue Ventures

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalDolby Family VenturesNoeticOMX Ventures+6 more

Ksana Healthksanahealth.cominJun 2021

Active seed-stage healthcare company

Eugene, US

Nicholas Allen(Chief Executive Officer)Phillip Scripa(Chief Financial Officer and Secretary)William Shortt(Chief Operating Officer)Jan Hardorp(Director)in

Co-investorsBIP VenturesJLSPalo Santo VC

Motif Neurotechmotifneuro.techin𝕏Jan 2024 · $19M

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsArboretum VenturesDivergent CapitalDolby Family VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture Fund+6 more

Precisionprecision.co𝕏Jan 2023 · $41M

Precision is an AI platform paired with operators who build, train, and run AI agents across a company's marketing, delivery, support, operations, and finance functions.

AI & Machine LearningEnterprise SoftwareSaaS

Matt Verlaque(Founder)in

Co-investorsRevUp Capital216 CapitalAlumni VenturesB CapitalB Capital GroupDraper Associates+3 more

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Founder)inThomas Oxley(Founder)inTom Oxley(Founder)

BoardRahul Sharma(Director)Alex Morgan(Director)in

Co-investorsAlumni VenturesARCH Venture PartnersForepont Capital PartnersID8 InvestmentsK2 GlobalKaleida Capital+15 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Blackrock Microsystems

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.